scholarly journals Heterogeneous alteration of the ERBB3–MYC axis associated with MEK inhibitor resistance in a KRAS-mutated low-grade serous ovarian cancer patient

2019 ◽  
Vol 5 (6) ◽  
pp. a004341 ◽  
Author(s):  
Ilaria Colombo ◽  
Swati Garg ◽  
Arnavaz Danesh ◽  
Jeffrey Bruce ◽  
Patricia Shaw ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Cancer Patient ◽  
Ovarian Cancer Patient ◽  
Mek Inhibitor ◽  
Low Grade ◽  
Serous Ovarian Cancer ◽  
Inhibitor Resistance

scholarly journals Markers of MEK inhibitor resistance in low-grade serous ovarian cancer: EGFR is a potential therapeutic target

2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Marta Llaurado Fernandez ◽  
Amy Dawson ◽  
Joshua Hoenisch ◽  
Hannah Kim ◽  
Sylvia Bamford ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Therapeutic Target ◽  
Mek Inhibitor ◽  
Low Grade ◽  
Serous Ovarian Cancer ◽  
Potential Therapeutic Target ◽  
Inhibitor Resistance

Synergistic effect of MEK inhibitor and metformin combination in low grade serous ovarian cancer

2017 ◽  
Vol 146 (2) ◽  
pp. 319-326 ◽  
Author(s):  
Ismail Mert ◽  
Jasdeep Chhina ◽  
Ghassan Allo ◽  
Jing Dai ◽  
Shelly Seward ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Synergistic Effect ◽  
Mek Inhibitor ◽  
Low Grade ◽  
Serous Ovarian Cancer

scholarly journals Two different, mutually exclusively distributed,TP53mutations in ovarian and peritoneal tumor tissues of a serous ovarian cancer patient: indicative for tumor origin?

2017 ◽  
Vol 3 (4) ◽  
pp. a001461 ◽  
Author(s):  
Nyamdelger Sukhbaatar ◽  
Anna Bachmayr-Heyda ◽  
Katharina Auer ◽  
Stefanie Aust ◽  
Simon Deycmar ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Cancer Patient ◽  
Ovarian Cancer Patient ◽  
Serous Ovarian Cancer ◽  
Peritoneal Tumor ◽  
Tumor Tissues ◽  
Tumor Origin

In vivo synergism between PARP-inhibitor olaparib and HSP90-inhibitor AT13387 in high grade serous ovarian cancer patient derived xenografts.

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. e17045-e17045 ◽  
Author(s):  
Panagiotis Konstantinopoulos ◽  
Sangeetha Palakurthi ◽  
Qing Zeng ◽  
Shan Zhou ◽  
Joyce F. Liu ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Cancer Patient ◽  
Ovarian Cancer Patient ◽  
Parp Inhibitor ◽  
Hsp90 Inhibitor ◽  
High Grade ◽  
Serous Ovarian Cancer
Sign in / Sign up

Export Citation Format

Share Document